Avitaz^TM

Indication:
• Complicated Intra-abdominal Infections (cIAI)
• Complicated Urinary Tract Infections (cUTI), including Pyelonephritis
• Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP)

Dosage & Administration:
It is recommended that this should be used to treat infections due to aerobic Gram-negative organisms in adults and paediatric patients with limited treatment options only after consultation with a physician with appropriate experience in the management of infectious diseases.
• Complicated intra-abdominal infection: 2 g/0.5 g, every 8 hours for 5-14 days.
• Complicated urinary tract infection (cUTI), including pyelonephritis: 2 g/0.5 g every 8 hours for 5-10 days.
• Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP): 2 g/0.5 g Every 8 hours for 7-14 days.
• Bacteraemia associated with, or suspected to be associated with any of the above infections: 2 g/0.5 g Every 8 hours. Duration of treatment should be in accordance with the site of infection.
• Infections due to aerobic Gram-negative organisms in patients with limited treatment options: 2 g/0.5 g Every 8 hours. Guided by the severity of the infection, the pathogen(s) and the patient’s clinical and bacteriological progress.

Preparation:
Avitaz^TM 2.5 gm powder for IV infusion: Each box contains 1 vial of 2.5 gm (Ceftazidime 2 gm and Avibactam 0.5 gm) with 1 ampoule of 10 ml Water for Injections BP (sterile).